Magnetic Ventures
Magnetic Ventures, founded in 2018, is a venture capital firm dedicated to backing visionary founders who use deep technology to transform the life sciences sector. The firm operates on the belief that technology will revolutionize every aspect of life sciences, and it focuses on early-stage investments across the life science ecosystem. Magnetic Ventures provides more than just capital; it offers unmatched resources to accelerate growth and maximize impact, helping founders navigate from seed through a company’s life cycle. The firm is committed to building the next generation of life science companies by identifying breakthrough opportunities at the earliest stages.
Services
Hands-on Support
Magnetic Ventures provides hands-on support during the most formative stages of company building, helping founders navigate from seed through a company’s life cycle.
Access to Resources
The firm offers unmatched resources to accelerate growth and maximize impact for its portfolio companies.
Strategic Guidance and Mentorship
Magnetic Ventures offers strategic guidance and mentorship to its portfolio companies, leveraging its deep industry expertise across technology and life sciences.
Networking Opportunities
The firm provides unparalleled connectivity to pharma, biotech, and funders, helping companies establish their message and engage partnerships.
Hands-on Support
Magnetic Ventures provides hands-on support during the most formative stages of company building, helping founders navigate from seed through a company’s life cycle.
Access to Resources
The firm offers unmatched resources to accelerate growth and maximize impact for its portfolio companies.
Strategic Guidance and Mentorship
Magnetic Ventures offers strategic guidance and mentorship to its portfolio companies, leveraging its deep industry expertise across technology and life sciences.
Networking Opportunities
The firm provides unparalleled connectivity to pharma, biotech, and funders, helping companies establish their message and engage partnerships.
Portfolio
Weave Bio leverages generative AI with AutoIND to transform the IND application process, expediting regulatory filings, cutting costs, and accelerating the delivery of life-saving therapies to patients.
#Life Sciences
Relation deploys active-graph machine learning (ML) combined with single-cell analysis to advance therapeutic candidates for diseases with no or few good medicines.
#TechBio
Resilience is changing the way complex medicines are made and distributed by leveraging technology innovation to better serve scientific discovery, withstand disruptive events, and reach those in need.
#Biotechnology
Paradigm is an intelligent, deep-tech clinical research platform that designs and runs more impactful clinical trials.
#Clinical Research
Deep Genomics uses artificial intelligence and machine learning to rapidly accelerate drug discovery and development for rare genetic and chronic diseases.
#Biotechnology
Terrain Bioscience is making better RNA faster, using AI/ML-guided optimization and improved manufacturing processes to accelerate therapeutic innovation for partners.
#Biotechnology
Weave Bio leverages generative AI with AutoIND to transform the IND application process, expediting regulatory filings, cutting costs, and accelerating the delivery of life-saving therapies to patients.
#Life Sciences
Relation deploys active-graph machine learning (ML) combined with single-cell analysis to advance therapeutic candidates for diseases with no or few good medicines.
#TechBio
Resilience is changing the way complex medicines are made and distributed by leveraging technology innovation to better serve scientific discovery, withstand disruptive events, and reach those in need.
#Biotechnology
Paradigm is an intelligent, deep-tech clinical research platform that designs and runs more impactful clinical trials.
#Clinical Research
Deep Genomics uses artificial intelligence and machine learning to rapidly accelerate drug discovery and development for rare genetic and chronic diseases.
#Biotechnology
Terrain Bioscience is making better RNA faster, using AI/ML-guided optimization and improved manufacturing processes to accelerate therapeutic innovation for partners.
#Biotechnology